Targeted Therapeutics Research

The long-term goal of our Targeted Therapeutics research program is to help people with a lung cancer diagnosis live longer and healthier lives. LUNGevity awardees are at the forefront of precision medicine — bringing the right therapy, in the right dose, to the right patient, at the right time — by answering these important questions:

  1. How can we match the right patient to the right therapies for maximum effectiveness and minimum side effects?
  2. How do we overcome resistance to therapies so that patients can benefit from them longer?
  3. How do we best sequence/combine therapies for maximum effect?
  4. How do we build on the early successes of immunotherapy?

Projects funded to date fall under the following categories.

Targeted therapies research projects

print